Stem cell therapies targeting key immune cells, such as T cells and NK cells, have been developed to facilitate a variety of disease treatment. To illustrate the mechanism of action for inducible pluripotent stem cells (iPSCs)-derived NK cell therapy, Creative Biolabs has established a panel of functional assays for effectively generating iPSC-derived NK cells and investigating their potency in disease therapy.